163 related articles for article (PubMed ID: 3924917)
1. Inhibition of disulfide bonding of von Willebrand protein by monensin results in small, functionally defective multimers.
Wagner DD; Mayadas T; Urban-Pickering M; Lewis BH; Marder VJ
J Cell Biol; 1985 Jul; 101(1):112-20. PubMed ID: 3924917
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization.
Wagner DD; Marder VJ
J Cell Biol; 1984 Dec; 99(6):2123-30. PubMed ID: 6334089
[TBL] [Abstract][Full Text] [Related]
3. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells.
Wagner DD; Olmsted JB; Marder VJ
J Cell Biol; 1982 Oct; 95(1):355-60. PubMed ID: 6754744
[TBL] [Abstract][Full Text] [Related]
4. Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor.
Wagner DD; Mayadas T; Marder VJ
J Cell Biol; 1986 Apr; 102(4):1320-4. PubMed ID: 3082891
[TBL] [Abstract][Full Text] [Related]
5. Comparison of secretion and subcellular localization of von Willebrand protein with that of thrombospondin and fibronectin in cultured human vascular endothelial cells.
Reinders JH; de Groot PG; Dawes J; Hunter NR; van Heugten HA; Zandbergen J; Gonsalves MD; van Mourik JA
Biochim Biophys Acta; 1985 Mar; 844(3):306-13. PubMed ID: 3882157
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain.
Wagner DD; Marder VJ
J Biol Chem; 1983 Feb; 258(4):2065-7. PubMed ID: 6600453
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation, activity and secretion of lipoprotein lipase in cultured brown adipocytes of newborn mice. Effect of tunicamycin, monensin, 1-deoxymannojirimycin and swainsonine.
Masuno H; Schultz CJ; Park JW; Blanchette-Mackie EJ; Mateo C; Scow RO
Biochem J; 1991 Aug; 277 ( Pt 3)(Pt 3):801-9. PubMed ID: 1831351
[TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets.
de Groot PG; Federici AB; de Boer HC; d'Alessio P; Mannucci PM; Sixma JJ
Proc Natl Acad Sci U S A; 1989 May; 86(10):3793-7. PubMed ID: 2657729
[TBL] [Abstract][Full Text] [Related]
9. In vitro multimerization of von Willebrand factor is triggered by low pH. Importance of the propolypeptide and free sulfhydryls.
Mayadas TN; Wagner DD
J Biol Chem; 1989 Aug; 264(23):13497-503. PubMed ID: 2788160
[TBL] [Abstract][Full Text] [Related]
10. An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor.
Lynch DC; Zimmerman TS; Ling EH; Browning PJ
J Clin Invest; 1986 Jun; 77(6):2048-51. PubMed ID: 3486890
[TBL] [Abstract][Full Text] [Related]
11. Von Willebrand protein binds to extracellular matrices independently of collagen.
Wagner DD; Urban-Pickering M; Marder VJ
Proc Natl Acad Sci U S A; 1984 Jan; 81(2):471-5. PubMed ID: 6320190
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of von Willebrand protein by human megakaryocytes.
Sporn LA; Chavin SI; Marder VJ; Wagner DD
J Clin Invest; 1985 Sep; 76(3):1102-6. PubMed ID: 2413071
[TBL] [Abstract][Full Text] [Related]
13. Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease.
Levene RB; Booyse FM; Chediak J; Zimmerman TS; Livingston DM; Lynch DC
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6550-4. PubMed ID: 3306682
[TBL] [Abstract][Full Text] [Related]
14. Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells.
Wagner DD; Fay PJ; Sporn LA; Sinha S; Lawrence SO; Marder VJ
Proc Natl Acad Sci U S A; 1987 Apr; 84(7):1955-9. PubMed ID: 3494248
[TBL] [Abstract][Full Text] [Related]
15. Isolation of a storage and secretory organelle containing Von Willebrand protein from cultured human endothelial cells.
Reinders JH; De Groot PG; Gonsalves MD; Zandbergen J; Loesberg C; Van Mourik JA
Biochim Biophys Acta; 1984 Jul; 804(3):361-9. PubMed ID: 6430353
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell-derived high molecular weight von Willebrand factor is converted into the plasma multimer pattern by granulocyte proteases.
Tsai HM; Nagel RL; Hatcher VB; Sussman II
Biochem Biophys Res Commun; 1989 Feb; 158(3):980-5. PubMed ID: 2493251
[TBL] [Abstract][Full Text] [Related]
17. Topology and order of formation of interchain disulfide bonds in von Willebrand factor.
Wagner DD; Lawrence SO; Ohlsson-Wilhelm BM; Fay PJ; Marder VJ
Blood; 1987 Jan; 69(1):27-32. PubMed ID: 3539228
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation.
Federici AB; Elder JH; De Marco L; Ruggeri ZM; Zimmerman TS
J Clin Invest; 1984 Dec; 74(6):2049-55. PubMed ID: 6239876
[TBL] [Abstract][Full Text] [Related]
19. Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly.
Mayadas TN; Wagner DD
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3531-5. PubMed ID: 1565649
[TBL] [Abstract][Full Text] [Related]
20. Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex.
Machamer CE; Cresswell P
Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1287-91. PubMed ID: 6608726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
